Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.

Take two mins to learn more

Nuformix

Nuformix

Nuformix

Nuformix is a pharmaceutical development company, founded in 2008 and based in London, specialising in developing new, patented, and improved drug forms for treating fibrosis and oncology. Using cocrystal technology, Nuformix focuses on repurposing known drugs to enhance their therapeutic potential.

Nuformix is a pharmaceutical development company, founded in 2008 and based in London, specialising in developing new, patented, and improved drug forms for treating fibrosis and oncology. Using cocrystal technology, Nuformix focuses on repurposing known drugs to enhance their therapeutic potential.

Nuformix

Nuformix

has Exited

has Exited

Delivered a 14.3x return on investment

Get in Touch with Our Team.

Get in Touch with Our Team.

Get in Touch with Our Team.

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by